SGS is a proud partner and exhibitor of Outsourcing in Clinical Trials USA Virtual Conference. Our experts will be pleased to share this virtual experience and welcome you to our virtual booth. Schedule a meeting with our experts.
The twelfth annual OCT New England event will be turning virtual in September to become OCT USA. This online conference will bring together over 1200 delegates for an intellectually driven two day program which will include high level case study presentations from industry leaders across the US.
Since publication of the ICH-GCP R2 addendum, risk based trial approaches have steadily made their way into the clinical drug development industry. The dynamic nature of risk based monitoring (RBM), with its focus on the most critical areas, makes it a unique asset for tackling today’s trial challenges in COVID-19 times. This presentation will show how applying RBM principles can help you to successfully adapt trial oversight activities to the changing environment and prepare for the future.
SGS provides clinical research and bioanalytical testing, with a focus on early stage development and biometrics. Delivering solutions in Europe and North America, SGS offers clinical trial services. SGS has its own clinical unit in Belgium, including a viral challenge testing facility and two phase I patient units based in Belgium and Hungary. SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high therapeutic focus in infectious diseases, vaccines, and respiratory:
To find out more, contact us today.
Clinical Research
t: +32 15 27 32 45